Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization

Derick Han, Garry Handelman, Lucia Marcocci, Chandan K. Sen, Sashwati Roy, Hirotsugu Kobuchi, Hans J. Tritschler, Leopold Flohé, Lester Packer

Research output: Contribution to journalArticle

285 Citations (Scopus)

Abstract

Lipoic acid (thiotic acid) is being used as a dietary supplement, and as a therapeutic agent, and is reported to have beneficial effects in disorders associated with oxidative stress, but its mechanism of action remains unclear. We present evidence that lipoic acid induces a substantial increase in cellular reduced glutathione in cultured human Jurkat T cells, human erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocytes. The effect depends on metabolic reduction of lipoic acid to dihydrolipoic acid. Dihydrolipoic acid is released into the culture medium where it reduces cystine. Cysteine thus formed is readily taken up by the neutral amino acid transport system and utilized for glutathione synthesis. By this mechanism lipoic acid enables cystine to bypass the x(c)- transport system, which is weakly expressed in lymphocytes and inhibited by glutamate. Thereby lipoic acid enables the key enzyme of glutathione synthesis, γ-glutamylcysteine synthetase, which is regulated by uptake-limited cysteine supply, to work at optimum conditions. Flow cytometric analysis of freshly prepared human peripheral blood lymphocytes, using monobromobimane labeling of cellular thiols, reveals that lipoic acid acts mainly to normalize a subpopulation of cells severely compromised in thiol status rather then to increase thiol content beyond physiological levels. Hence lipoic acid may have clinical relevance in restoration of severely glutathione deficient cells.

Original languageEnglish
Pages (from-to)321-338
Number of pages18
JournalBioFactors
Volume6
Issue number3
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Thioctic Acid
Cystine
Glutathione
Lymphocytes
Sulfhydryl Compounds
Cysteine
Blood
Neutral Amino Acid Transport Systems
Dietary supplements
Glutamate-Cysteine Ligase
Oxidative stress
Jurkat Cells
T-cells
Dietary Supplements
Neuroblastoma
Neuroglia
Labeling
Restoration
Culture Media
Glutamic Acid

Keywords

  • ASC transporter
  • Cysteine uptake
  • Jurkat cells
  • Peripheral blood lymphocytes
  • Thiols
  • x(c) transporter

ASJC Scopus subject areas

  • Biochemistry

Cite this

Han, D., Handelman, G., Marcocci, L., Sen, C. K., Roy, S., Kobuchi, H., ... Packer, L. (1997). Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors, 6(3), 321-338.

Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. / Han, Derick; Handelman, Garry; Marcocci, Lucia; Sen, Chandan K.; Roy, Sashwati; Kobuchi, Hirotsugu; Tritschler, Hans J.; Flohé, Leopold; Packer, Lester.

In: BioFactors, Vol. 6, No. 3, 1997, p. 321-338.

Research output: Contribution to journalArticle

Han, D, Handelman, G, Marcocci, L, Sen, CK, Roy, S, Kobuchi, H, Tritschler, HJ, Flohé, L & Packer, L 1997, 'Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization', BioFactors, vol. 6, no. 3, pp. 321-338.
Han, Derick ; Handelman, Garry ; Marcocci, Lucia ; Sen, Chandan K. ; Roy, Sashwati ; Kobuchi, Hirotsugu ; Tritschler, Hans J. ; Flohé, Leopold ; Packer, Lester. / Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. In: BioFactors. 1997 ; Vol. 6, No. 3. pp. 321-338.
@article{08cd7a59f17a46249f4c5bab48f929da,
title = "Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization",
abstract = "Lipoic acid (thiotic acid) is being used as a dietary supplement, and as a therapeutic agent, and is reported to have beneficial effects in disorders associated with oxidative stress, but its mechanism of action remains unclear. We present evidence that lipoic acid induces a substantial increase in cellular reduced glutathione in cultured human Jurkat T cells, human erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocytes. The effect depends on metabolic reduction of lipoic acid to dihydrolipoic acid. Dihydrolipoic acid is released into the culture medium where it reduces cystine. Cysteine thus formed is readily taken up by the neutral amino acid transport system and utilized for glutathione synthesis. By this mechanism lipoic acid enables cystine to bypass the x(c)- transport system, which is weakly expressed in lymphocytes and inhibited by glutamate. Thereby lipoic acid enables the key enzyme of glutathione synthesis, γ-glutamylcysteine synthetase, which is regulated by uptake-limited cysteine supply, to work at optimum conditions. Flow cytometric analysis of freshly prepared human peripheral blood lymphocytes, using monobromobimane labeling of cellular thiols, reveals that lipoic acid acts mainly to normalize a subpopulation of cells severely compromised in thiol status rather then to increase thiol content beyond physiological levels. Hence lipoic acid may have clinical relevance in restoration of severely glutathione deficient cells.",
keywords = "ASC transporter, Cysteine uptake, Jurkat cells, Peripheral blood lymphocytes, Thiols, x(c) transporter",
author = "Derick Han and Garry Handelman and Lucia Marcocci and Sen, {Chandan K.} and Sashwati Roy and Hirotsugu Kobuchi and Tritschler, {Hans J.} and Leopold Floh{\'e} and Lester Packer",
year = "1997",
language = "English",
volume = "6",
pages = "321--338",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization

AU - Han, Derick

AU - Handelman, Garry

AU - Marcocci, Lucia

AU - Sen, Chandan K.

AU - Roy, Sashwati

AU - Kobuchi, Hirotsugu

AU - Tritschler, Hans J.

AU - Flohé, Leopold

AU - Packer, Lester

PY - 1997

Y1 - 1997

N2 - Lipoic acid (thiotic acid) is being used as a dietary supplement, and as a therapeutic agent, and is reported to have beneficial effects in disorders associated with oxidative stress, but its mechanism of action remains unclear. We present evidence that lipoic acid induces a substantial increase in cellular reduced glutathione in cultured human Jurkat T cells, human erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocytes. The effect depends on metabolic reduction of lipoic acid to dihydrolipoic acid. Dihydrolipoic acid is released into the culture medium where it reduces cystine. Cysteine thus formed is readily taken up by the neutral amino acid transport system and utilized for glutathione synthesis. By this mechanism lipoic acid enables cystine to bypass the x(c)- transport system, which is weakly expressed in lymphocytes and inhibited by glutamate. Thereby lipoic acid enables the key enzyme of glutathione synthesis, γ-glutamylcysteine synthetase, which is regulated by uptake-limited cysteine supply, to work at optimum conditions. Flow cytometric analysis of freshly prepared human peripheral blood lymphocytes, using monobromobimane labeling of cellular thiols, reveals that lipoic acid acts mainly to normalize a subpopulation of cells severely compromised in thiol status rather then to increase thiol content beyond physiological levels. Hence lipoic acid may have clinical relevance in restoration of severely glutathione deficient cells.

AB - Lipoic acid (thiotic acid) is being used as a dietary supplement, and as a therapeutic agent, and is reported to have beneficial effects in disorders associated with oxidative stress, but its mechanism of action remains unclear. We present evidence that lipoic acid induces a substantial increase in cellular reduced glutathione in cultured human Jurkat T cells, human erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocytes. The effect depends on metabolic reduction of lipoic acid to dihydrolipoic acid. Dihydrolipoic acid is released into the culture medium where it reduces cystine. Cysteine thus formed is readily taken up by the neutral amino acid transport system and utilized for glutathione synthesis. By this mechanism lipoic acid enables cystine to bypass the x(c)- transport system, which is weakly expressed in lymphocytes and inhibited by glutamate. Thereby lipoic acid enables the key enzyme of glutathione synthesis, γ-glutamylcysteine synthetase, which is regulated by uptake-limited cysteine supply, to work at optimum conditions. Flow cytometric analysis of freshly prepared human peripheral blood lymphocytes, using monobromobimane labeling of cellular thiols, reveals that lipoic acid acts mainly to normalize a subpopulation of cells severely compromised in thiol status rather then to increase thiol content beyond physiological levels. Hence lipoic acid may have clinical relevance in restoration of severely glutathione deficient cells.

KW - ASC transporter

KW - Cysteine uptake

KW - Jurkat cells

KW - Peripheral blood lymphocytes

KW - Thiols

KW - x(c) transporter

UR - http://www.scopus.com/inward/record.url?scp=0030696877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030696877&partnerID=8YFLogxK

M3 - Article

C2 - 9288403

AN - SCOPUS:0030696877

VL - 6

SP - 321

EP - 338

JO - BioFactors

JF - BioFactors

SN - 0951-6433

IS - 3

ER -